Healthcare -
Biotechnology - NASDAQ - US
$ 85.3
-2.88 %
$ 10.6 B
Market Cap
-18.87
P/E
PCVX - LONG-TERM DEBT
Long-term Debt PCVX - Vaxcyte, Inc.
22.1 M
LAST VALUE
38.62%
2 YEAR CAGR
167.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR